» Articles » PMID: 17574970

Rearrangements Involving 12q in Myeloproliferative Disorders: Possible Role of HMGA2 and SOCS2 Genes

Overview
Date 2007 Jun 19
PMID 17574970
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

We report two cases of translocation associated with deletion on derivative chromosomes in atypical myeloproliferative disorder (MPD). In a MPD with t(3;12)(q29;q14), the rearrangement targeted the HMGA2 locus at 12q14 and deleted a region of about 1.5 megabases (Mb) at 3q29. In an MPD with t(9;12)(q13 approximately q21;q22) and JAK2 V617F mutation, array comparative genomic hybridization delineated a deletion of about 3 Mb at 9q13 approximately q21 and a deletion of about 2 Mb at 12q22 containing SOCS2. These results show that close examination of translocations in hematopoietic diseases may reveal associated microdeletions. The role of these deletions is discussed.

Citing Articles

Loss of Socs2 improves molecular responses to IFNα in a mouse model of myeloproliferative neoplasms driven by JAK2-V617F.

Usart M, Kimmerlin Q, Stetka J, Stoll C, Rai S, Almeida Fonseca T Leukemia. 2025; .

PMID: 40069287 DOI: 10.1038/s41375-025-02550-5.


HMGA2 overexpression with specific chromosomal abnormalities predominate in CALR and ASXL1 mutated myelofibrosis.

Handa S, Schaniel C, Tripodi J, Ahire D, Mia M, Klingborg S Leukemia. 2024; 39(3):663-674.

PMID: 39715853 PMC: 11879852. DOI: 10.1038/s41375-024-02496-0.


Decoding the pathological and genomic profile of epithelial ovarian cancer.

Rejaibi R, Guille A, Manai M, Adelaide J, Agavnian E, Jelassi A Sci Rep. 2024; 14(1):28573.

PMID: 39562613 PMC: 11577113. DOI: 10.1038/s41598-024-80030-z.


Cellular carcinogenesis in preleukemic conditions:drivers and defenses.

Ueda K, Ikeda K Fukushima J Med Sci. 2023; 70(1):11-24.

PMID: 37952978 PMC: 10867434. DOI: 10.5387/fms.2023-17.


HMGA Proteins in Hematological Malignancies.

Minervini A, Coccaro N, Anelli L, Zagaria A, Specchia G, Albano F Cancers (Basel). 2020; 12(6).

PMID: 32503270 PMC: 7353061. DOI: 10.3390/cancers12061456.